z-logo
open-access-imgOpen Access
Amikacin-resistant Acinetobacter species mediated by the aphA6 gene associated with clinical outcome at an academic complex hospital in KwaZulu-Natal Province, South Africa
Author(s) -
Khine Swe Swe-Han,
Manormoney Pillay
Publication year - 2019
Publication title -
samj. south african medical journal/south african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 57
eISSN - 2078-5135
pISSN - 0256-9574
DOI - 10.7196/samj.2019.v110i1.14045
Subject(s) - amikacin , acinetobacter , medicine , drug resistance , microbiology and biotechnology , multiple drug resistance , antibiotics , antimicrobial , antibiotic resistance , biology
Drug-resistant Acinetobacter species present serious therapeutic and infection control policy challenges globally. Although aminoglycosides have played a crucial role in the treatment of infections with multidrug-resistant (MDR) Acinetobacter spp., recent reports indicate that these bacteria are developing resistance to aminoglycosides around the globe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here